Apprentice Levy For Life Sciences: A solution for employing talent in clinical trials

As part of our Clinical Trials Day content, Clinical Professionals Director; Sarah Goddard explains how the Apprenticeship Levy could help kick start a career in clinical trials… There are apprenticeships that have been running very successfully for some time now within the scientific and manufacturing spaces, but the clinical trials industry has only just started to

Continue Reading

Johnson & Johnsons receives mixed success at Phase 3 trials for their antidepressant, esketamine

JnJ have revealed new data on its new depression drug esketamine, its chemically ‘left-handed’ version of the controlled anaesthetic often used recreationally, creating a varied viewed of its efficacy. JnJ’s drug, which is delivered by a nasal spray, was tested in treatment-resistant depression, defined as unaffected by two or more currently available antidepressant medications of

Continue Reading

AbbVie’s and Neurocrine Biosciences’ treatment for uterine fibroids successfully completes phase III trial

AbbVie and Neurocrine Biosciences announced that the second positive phase III trial was successful for their uterine fibroids drug elagolix, enabling another regulatory filing for the drug. Both companies are currently waiting for an FDA verdict in the US in the coming weeks on elagolix as a treatment for endometriosis-related pain, although uterine fibroids are

Continue Reading

UK Biotech given green light to begin stem cell therapy clinical trial for heart failure

UK biotech, Celixir, has received a green light to start a phase IIb trial of HeartCel, its stem cell-based therapy for heart failure, that could potentially support approval. Heartcel is a preparation of off-the-shelf immunomodulatory progenitor (iMP) cells that are injected around cardiac scar tissue during coronary artery bypass graft (CABG) surgery in the hope

Continue Reading

Recent study data by the FDA has found that older blood cancer patients (75+) are severely under-represented in clinical trials

Results from the FDA’s first comprehensive examination of clinical trial enrolment in older patients with blood cancers has revealed that patients over 75 are significantly underrepresented. When looking at the occurrence of these conditions, it has recently been found that one in five patients in the US who are diagnosed with blood cancer are over

Continue Reading

CCRA AGM Roundup 2017

Housed within the dramatic and suitably clinical-feeling Miller Insurance offices near Aldgate in London, a gathering of great clinical minds occurred for the CCRA AGM. Professor Atholl Johnston, President, opened up the day with introductions before we launched into 5 presentations back-to-back. Firstly we heard from Andy Catton, a Partner at Miller Insurance, on specialist

Continue Reading